Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,567,948
+$4,702,582 QoQ
Shares Held
1,091,177
+2.3% QoQ
Ownership
1.47%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. XNCR ranks #28 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,567,948 | 1,091,177 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,865,366 | 1,066,780 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $20,026,826 | 1,308,088 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $14,932,289 | 1,273,000 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,421,911 | 180,905 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,953,791 | 183,627 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,400,991 | 191,514 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,357,082 | 166,936 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $3,484,539 | 184,075 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $4,168,915 | 188,383 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $3,609,544 | 170,021 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $3,378,429 | 167,664 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,591,781 | 223,940 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,625,296 | 237,551 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,777,859 | 221,884 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,437,016 | 209,277 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,711,581 | 172,144 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $4,768,142 | 178,716 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,027,329 | 200,083 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,352,499 | 194,504 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,217,887 | 151,287 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $8,173,863 | 189,825 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,137,779 | 186,518 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,216,219 | 186,033 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,135,239 | 158,544 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,379,840 | 146,581 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||